

Table of Contents

1 Introduction (Page No. - 14)

1.1 Objectives of the Study

1.2 Market Definition

1.3 Market Scope

1.3.1 Markets Covered

1.3.2 Years Considered for the Study

1.4 Currency

1.5 Limitations

1.6 Stakeholders

2 Research Methodology (Page No. - 18)

2.1 Research Data

2.1.1 Secondary Data

2.1.1.1 Secondary Sources

2.1.2 Primary Data

2.1.3 Primary Sources

2.1.3.1 Key Insights From Primary Sources

2.1.3.2 Market Size Estimation Methodology

2.1.4 Market Data Estimation and Triangulation

2.2 Assumptions

3 Executive Summary (Page No. - 28)

4 Premium Insights (Page No. - 32)

4.1 Infusion Pump Software Market Overview

4.2 Geographic Analysis: European Infusion Pump Software Market Share, By Type, 2019

4.3 Infusion Pump Software Market Share, By Indication, 2019 vs. 2024

4.4 Infusion Pump Software Market Share, By Type, 2019 vs. 2024

4.5 Infusion Pump Software Market Share, By End User, 2019 vs. 2024

4.6 Infusion Pump Software Market: Geographical Snapshot

5 Market Overview (Page No. - 36)

5.1 Introduction

5.2 Market Dynamics

5.2.1 Market Drivers

5.2.1.1 Increasing Incidence of Chronic Diseases and Rapid Growth in Geriatric Population

5.2.1.2 Growing Number of Surgical Procedures Performed

5.2.1.3 Rising Demand for Ambulatory and Home Care Infusion Pumps

5.2.1.4 Technological Developments

5.2.2 Market Restraints

5.2.2.1 Frequent Product Recalls of Infusion Pumps

5.2.3 Market Opportunities

5.2.3.1 Untapped Emerging Markets

5.2.3.2 Growing Adoption of Specialty Infusion Systems

5.2.4 Challenges

5.2.4.1 Increasing Incidence of Medication Errors and Lack of Wireless Connectivity in Most Hospitals

6 Infusion Pump Software Market, By Type (Page No. - 43)

6.1 Introduction

6.2 Dose Error Reduction Software (DERS)

6.2.1 Increasing Incidence of Medication Errors is Driving the Demand for DERS in Infusion Pumps

6.3 Clinical Workflow Software

6.3.1 Clinical Workflow Software Enables Automation of the Entire Process of A Patient�s Assessment and Treatment

6.4 Interoperability Software

6.4.1 Interoperability Software Helps in Reducing Manual Programming Errors

6.5 Others

7 Infusion Pump Software Market, By Indication (Page No. - 50)

7.1 Introduction

7.2 General Infusion

7.2.1 Availability of Safer and Efficient Infusion Pumps to Propel the Market for General Infusion

7.3 Pain & Anesthesia Management

7.3.1 High Incidence of Chronic Pain Will Drive the Market for Pain Management

7.4 Insulin Infusion

7.4.1 Significant Increase in the Global Prevalence of Diabetes Will Drive Market Growth

7.5 Chemotherapy

7.5.1 Demand for Controlled and Targeted Delivery of Medication to Drive the Chemotherapy Market

7.6 Enteral Infusion

7.6.1 Infusion Pumps Facilitate Continuous and Controlled Parenteral Flow

7.7 Other Indications

8 Infusion Pump Software Market, By End User (Page No. - 59)

8.1 Introduction

8.2 Hospitals

8.2.1 Hospitals Dominate the Infusion Pump Software Market, By End User

8.3 Ambulatory Care Settings

8.3.1 Need to Reduce Healthcare Expenditure has Boosted the Preference for Ambulatory Care

8.4 Home Care Settings

8.4.1 Rising Acceptance and Cost-Efficiency of Home Care Products Have Driven their Use

8.5 Academic & Research Institutes

8.5.1 Rising Drug Discovery Activity and Incidence of Medication Errors is Driving Market Growth

9 Infusion Pump Software Market, By Region (Page No. - 66)

9.1 Introduction

9.2 North America

9.2.1 US

9.2.1.1 US is the Largest Market for Infusion Pump Software

9.2.2 Canada

9.2.2.1 Favorable Reimbursement Scenario for Infusion Pumps to Propel the Market in Canada

9.3 Europe

9.3.1 Germany

9.3.1.1 Germany is the Fastest-Growing Market for Infusion Pump Software in Europe

9.3.2 France

9.3.2.1 The Healthcare System in France is Among the Best in the World

9.3.3 UK

9.3.3.1 High Number of Medication Errors in the UK to Drive Market Growth

9.3.4 RoE

9.4 APAC

9.4.1 China

9.4.1.1 Growing Investments in Healthcare Infrastructure to Support Market Growth

9.4.2 Japan

9.4.2.1 Rapid Growth in the Geriatric Population and the Rising Prevalence of Age-Related Illnesses to Drive Market Growth

9.4.3 India

9.4.3.1 High Prevalence of Lifestyle Diseases to Drive the Market for Infusion Pump Software

9.4.4 RoAPAC

9.5 Rest of the World

10 Competitive Landscape (Page No. - 104)

10.1 Overview

10.1.1 Market Ranking of Players, 2018

10.2 Competitive Leadership Mapping

10.2.1 Visionary Leaders

10.2.2 Innovators

10.2.3 Dynamic Differentiators

10.2.4 Emerging Companies

10.3 Competitive Scenario

10.3.1 Product Launches

10.3.2 Expansions

10.3.3 Partnerships, Agreements, and Collaborations

10.3.4 Acquisitions

11 Company Profiles (Page No. - 112)

11.1 Becton, Dickinson and Company (BD)

11.2 B. Braun Melsungen AG (B. Braun)

11.3 Baxter International Inc. (Baxter)

11.4 Fresenius Kabi

11.5 ICU Medical, Inc. (ICU Medical)

11.6 Medtronic Plc (Medtronic)

11.7 Moog Inc. (Moog)

11.8 Smiths Medical (A Division of Smiths Group Plc)

11.9 Terumo Corporation

11.10 Roche Diagnostics (A Division of F. Hoffmann- La Roche Ltd.)

11.11 Ypsomed AG (Ypsomed)

11.12 Micrel Medical Devices

12 Appendix (Page No. - 140)

12.1 Discussion Guide

12.2 Knowledge Store: Marketsandmarkets� Subscription Portal

12.3 Available Customizations

12.4 Related Reports

12.5 Author Details



List of Tables (69 Tables)

Table 1 Indicative List of Product Recalls for Infusion Pump Software (2015�2017)

Table 2 Infusion Pump Software Market, By Type, 2017�2024 (USD Million)

Table 3 Market, By Region, 2017�2024 (USD Million)

Table 4 Market for Ders, By Region, 2017�2024 (USD Million)

Table 5 Infusion Pump Clinical Workflow Software Market, By Region, 2017�2024 (USD Million)

Table 6 Infusion Pump Interoperability Software Market, By Region, 2017�2024 (USD Million)

Table 7 Other Infusion Pump Software Market, By Region, 2017�2024 (USD Million)

Table 8 Market, By Indication, 2017�2024 (USD Million)

Table 9 Market for General Infusion, By Region, 2017�2024 (USD Million)

Table 10 Market for Pain & Anesthesia Management, By Region, 2017�2024 (USD Million)

Table 11 Market for Insulin Infusion, By Region, 2017�2024 (USD Million)

Table 12 Market for Chemotherapy, By Region, 2017�2024 (USD Million)

Table 13 Market for Enteral Infusion, By Region,2017�2024 (USD Million)

Table 14 Market for Other Indications, By Region, 2017�2024 (USD Million)

Table 15 Market, By End User, 2017�2024 (USD Million)

Table 16 Market for Hospitals, By Region, 2017�2024 (USD Million)

Table 17 Market for Ambulatory Care Settings, By Region, 2017�2024 (USD Million)

Table 18 Market for Home Care Settings, By Region, 2017�2024 (USD Million)

Table 19 Market for Academic & Research Institutes, By Region, 2017�2024 (USD Million)

Table 20 Market, By Region, 2017�2024 (USD Million)

Table 21 North America: Market, By Country, 2017�2024 (USD Million)

Table 22 North America: Market, By Type, 2017�2024 (USD Million)

Table 23 North America: Market, By Indication, 2017�2024 (USD Million)

Table 24 North America: Market, By End User, 2017�2024 (USD Million)

Table 25 US: Market, By Type, 2017�2024 (USD Million)

Table 26 US: Market, By Indication, 2017�2024 (USD Million)

Table 27 US: Market, By End User, 2017�2024 (USD Million)

Table 28 Canada: Market, By Type, 2017�2024 (USD Million)

Table 29 Canada: Market, By Indication, 2017�2024 (USD Million)

Table 30 Canada: Market, By End User, 2017�2024 (USD Million)

Table 31 Europe: Market, By Country, 2017�2024 (USD Million)

Table 32 Europe: Market, By Type, 2017�2024 (USD Million)

Table 33 Europe: Market, By Indication, 2017�2024 (USD Million)

Table 34 Europe: Market, By End User, 2017�2024 (USD Million)

Table 35 Germany: Market, By Type, 2017�2024 (USD Million)

Table 36 Germany: Market, By Indication, 2017�2024 (USD Million)

Table 37 Germany: Market, By End User, 2017�2024 (USD Million)

Table 38 France: Market, By Type, 2017�2024 (USD Million)

Table 39 France: Market, By Indication, 2017�2024 (USD Million)

Table 40 France: Market, By End User, 2017�2024 (USD Million)

Table 41 UK: Market, By Type, 2017�2024 (USD Million)

Table 42 UK: Market, By Indication, 2017�2024 (USD Million)

Table 43 UK: Market, By End User, 2017�2024 (USD Million)

Table 44 RoE: Market, By Type, 2017�2024 (USD Million)

Table 45 RoE: Market, By Indication, 2017�2024 (USD Million)

Table 46 RoE: Market, By End User, 2017�2024 (USD Million)

Table 47 Asia Pacific Market, By Country, 2017�2024 (USD Million)

Table 48 Asia Pacific: Market, By Type, 2017�2024 (USD Million)

Table 49 Asia Pacific: Market, By Indication, 2017�2024 (USD Million)

Table 50 Asia Pacific: Market, By End User, 2017�2024 (USD Million)

Table 51 China: Market, By Type, 2017�2024 (USD Million)

Table 52 China: Market, By Indication, 2017�2024 (USD Million)

Table 53 China: Market, By End User, 2017�2024 (USD Million)

Table 54 Japan: Market, By Type, 2017�2024 (USD Million)

Table 55 Japan: Market, By Indication, 2017�2024 (USD Million)

Table 56 Japan: Market, By End User, 2017�2024 (USD Million)

Table 57 India: Market, By Type, 2017�2024 (USD Million)

Table 58 India: Market, By Indication, 2017�2024 (USD Million)

Table 59 India: Market, By End User, 2017�2024 (USD Million)

Table 60 RoAPAC : Market, By Type, 2017�2024 (USD Million)

Table 61 RoAPAC : Market, By Indication, 2017�2024 (USD Million)

Table 62 RoAPAC : Market, By End User, 2017�2024 (USD Million)

Table 63 RoW: Market, By Type, 2017�2024 (USD Million)

Table 64 RoW: Market, By Indication, 2017�2024 (USD Million)

Table 65 RoW: Market, By End User, 2017�2024 (USD Million)

Table 66 Product Launches and Approvals

Table 67 Expansions

Table 68 Partnerships, Agreements, and Collaborations

Table 69 Acquisitions



List of Figures (41 Figures)

Figure 1 Research Methodology Steps

Figure 2 Research Design

Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region

Figure 4 Market : Bottom-Up Approach

Figure 5 Market: Top-Down Approach

Figure 6 Data Triangulation Methodology

Figure 7 Market, By Type, 2019 vs. 2024 (USD Million)

Figure 8 Market Share, By Indication, 2019 vs. 2024 (USD Million)

Figure 9 Market Share, By End User, 2018

Figure 10 Geographical Snapshot of the Infusion Pump Software Market

Figure 11 Increasing Incidence of Chronic Diseases to Drive the Growth of the Market During the Forecast Period

Figure 12 Germany to Account for the Largest Share in the European Infusion Pump Software Market in 2019

Figure 13 General Infusion Segment to Dominate the Infusion Pump Software Market During the Forecast Period

Figure 14 DERS Segment to Account for the Dominant Share of the Market in 2019

Figure 15 Hospitals to Dominate the Infusion Pump Software Market in 2024

Figure 16 APAC to Register the Highest CAGR During the Forecast Period

Figure 17 Infusion Pump Software Market: Drivers, Restraints, Opportunities, and Challenges

Figure 18 Global Cancer Incidence, 2008�2030

Figure 19 Estimated Diabetic Population, By Region, 2015 vs. 2040

Figure 20 DERS Segment to Witness the Highest Growth in the Infusion Pump Software Market During the Forecast Period

Figure 21 Insulin Infusion Segment to Grow at the Highest CAGR During the Forecast Period

Figure 22 Hospitals to Account for the Largest Share in the Infusion Pump Software Market in 2018

Figure 23 North America Accounted for the Largest Share of the Infusion Pump Software Market in 2018

Figure 24 North America: Market Snapshot

Figure 25 Europe: Market Snapshot

Figure 26 APAC: Market Snapshot

Figure 27 RoW: Market Snapshot

Figure 28 Key Developments in the Infusion Pump Software Market Between 2016 and 2018

Figure 29 Market Ranking, By Key Player

Figure 30 Market, Competitive Leadership Mapping, 2018

Figure 31 Becton, Dickinson and Company: Company Snapshot (2018)

Figure 32 B. Braun: Company Snapshot (2017)

Figure 33 Baxter: Company Snapshot (2017)

Figure 34 Fresenius Kabi: Company Snapshot (2017)

Figure 35 ICU Medical: Company Snapshot (2017)

Figure 36 Medtronic: Company Snapshot (2017)

Figure 37 Moog: Company Snapshot (2018)

Figure 38 Smiths Medical: Company Snapshot (2018)

Figure 39 Terumo Corporation: General Hospital Company Segment Snapshot (2017)

Figure 40 Roche: Company Snapshot (2018)

Figure 41 Ypsomed: Company Snapshot (2017)